ASHNYSEWholesale-Chemicals & Allied ProductsFiscal year ends September 30
ASHLAND INC.
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026
$71.19+0.04 (+0.06%)
Close on Oct 19, 2026
- Market cap
- $3.27K
- P/E (TTM)
- –
- Dividend yield
- 2.30%
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
100.0%
52M of 46M shares
Institutional holders
354
66 new, 56 sold out
Net institutional buying
3M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 5,643,843 | 12.30% | 13G (passive) amendment | Jun 30, 2026 |
| Standard Latitude Master Fund Ltd. | 4,095,001 | 8.94% | 13D (active) amendment | May 15, 2026 |
| Franklin Resources, Inc. | 3,616,479 | 7.90% | 13G (passive) | Jun 30, 2026 |
| AQR Capital Management, LLC | 3,454,646 | 7.56% | 13G (passive) | Jun 30, 2025 |
| Cooperman Leon G | 2,915,000 | 6.40% | 13G (passive) | Jul 29, 2026 |
| Standard Latitude Fund LP | 2,625,000 | 5.70% | 13D (active) | Nov 21, 2025 |
| Dimensional Fund Advisors LP | 2,496,021 | 5.50% | 13G (passive) | Mar 31, 2026 |
| Vanguard Portfolio Management | 2,482,141 | 5.42% | 13G (passive) | Jun 30, 2026 |
| Vanguard Capital Management | 2,404,559 | 5.25% | 13G (passive) | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ASH | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 5,712,189 | 12.47% | $376.38M | +1,417,278 | 0.01% |
| Standard Investments LLC | 4,525,001 | 9.88% | $298.15M | +1,900,001 | 15.44% |
| Franklin Resources Inc | 3,616,479 | 7.90% | $238.29M | +1,874,130 | 0.05% |
| Dimensional Fund Advisors LP | 2,486,307 | 5.43% | $163.82M | −9,714 | 0.03% |
| Vanguard Portfolio Management LLC | 2,462,838 | 5.38% | $162.28M | +267,893 | 0.01% |
| Vanguard Capital Management LLC | 2,063,055 | 4.51% | $135.93M | +10,513 | 0.00% |
| Massachusetts Financial Services Co /Ma/ | 2,037,663 | 4.45% | $134.26M | −777,224 | 0.04% |
| Frontier Capital Management Co LLC | 1,999,908 | 4.37% | $131.77M | +87,219 | 1.23% |
| Ancora Advisors, LLC | 1,945,412 | 4.25% | $128.18M | +1,945,112 | 2.47% |
| Cooperman Leon G | 1,895,000 | 4.14% | $124.86M | +195,000 | 3.52% |
| State Street Corp | 1,891,594 | 4.13% | $124.64M | +351,766 | 0.00% |
| Aqr Capital Management LLC | 1,823,353 | 3.98% | $116.77M | −188,171 | 0.04% |
| Diamond Hill Capital Management Inc | 1,600,714 | 3.50% | $105.47M | −149,773 | 0.84% |
| 1832 Asset Management L.P. | 1,409,124 | 3.08% | $92.85M | −6,296 | 0.05% |
| Geode Capital Management, LLC | 1,249,931 | 2.73% | $82.37M | +400,996 | 0.00% |
| Thrivent Financial for Lutherans | 1,029,179 | 2.25% | $67.81K | −627 | 0.11% |
| American Century Companies Inc | 919,239 | 2.01% | $60.57M | −221,460 | 0.03% |
| Northern Trust Corp | 760,083 | 1.66% | $50.08M | +274,809 | 0.01% |
| Empyrean Capital Partners, LP | 542,000 | 1.18% | $35.71M | – | 1.18% |
| Charles Schwab Investment Management Inc | 540,444 | 1.18% | $35.61M | +114,940 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 354 | 52M | 100.0% | 66 / 105 | 124 / 56 | 12M | 9M |
| Q1 2026 | 349 | 49M | 100.0% | 59 / 122 | 107 / 36 | 9M | 4M |
| Q4 2025 | 332 | 48M | 100.0% | 55 / 91 | 139 / 69 | 11M | 7M |
| Q3 2025 | 355 | 45M | 97.3% | 55 / 99 | 149 / 42 | 6M | 6M |
| Q2 2025 | 345 | 44M | 96.1% | 53 / 139 | 107 / 72 | 7M | 5M |
| Q1 2025 | 367 | 43M | 93.7% | 69 / 132 | 107 / 58 | 7M | 9M |
| Q4 2024 | 359 | 45M | 97.3% | 56 / 120 | 128 / 60 | 5M | 4M |
| Q3 2024 | 368 | 44M | 96.8% | 48 / 105 | 142 / 57 | 8M | 5M |
| Q2 2024 | 379 | 46M | 99.7% | 51 / 132 | 118 / 42 | 3M | 4M |
| Q1 2024 | 372 | 47M | 100.0% | 72 / 110 | 113 / 32 | 3M | 3M |
| Q4 2023 | 335 | 48M | 100.0% | 52 / 102 | 120 / 36 | 4M | 4M |
| Q3 2023 | 323 | 47M | 100.0% | 42 / 106 | 115 / 54 | 5M | 5M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of ASH | Value | % of fund | As of |
|---|---|---|---|---|---|
| Franklin Small Cap Value Fund | 1,841,188 | 4.02% | $133.69M | 3.12% | Jul 31, 2026 |
| iShares Core S&P Mid-Cap ETF | 1,565,498 | 3.42% | $103.15M | 0.08% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 1,454,480 | 3.18% | $95.84M | 0.00% | Jun 30, 2026 |
| MFS Mid Cap Value Fund | 1,283,827 | 2.80% | $84.59M | 0.49% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 1,199,295 | 2.62% | $79.02M | 0.10% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 1,051,330 | 2.30% | $69.27M | 0.04% | Jun 30, 2026 |
| Thrivent Small Cap Stock Fund | 665,905 | 1.45% | $48.35M | 1.66% | Jul 31, 2026 |
| Vanguard Small-Cap Value Index Fund | 665,193 | 1.45% | $43.83M | 0.06% | Jun 30, 2026 |
| Franklin Small Cap Value VIP Fund | 652,030 | 1.42% | $42.96M | 3.28% | Jun 30, 2026 |
| U.S. Small Cap Value Portfolio | 608,227 | 1.33% | $44.16M | 0.23% | Jul 31, 2026 |
| Vanguard Extended Market Index Fund | 525,834 | 1.15% | $34.65M | 0.04% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 508,244 | 1.11% | $36.90M | 0.11% | Jul 31, 2026 |
| Diamond Hill Long Short Fund | 494,019 | 1.08% | $32.55M | 1.54% | Jun 30, 2026 |
| Bridge Builder Small/Mid Cap Value Fund | 444,010 | 0.97% | $29.26M | 0.28% | Jun 30, 2026 |
| MFS New Discovery Value Fund | 437,958 | 0.96% | $25.36M | 1.02% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Guillermo Novo | Chair of the Board and CEO, Director | 172,143 | 0.38% | Feb 10, 2026 |
| Osama M. Musa | SVP and CTO | 37,577 | 0.08% | Sep 23, 2026 |
| Robin E. Lampkin | SVP, GC & Secretary | 7,690 | 0.02% | Aug 12, 2026 |
| Alessandra Faccin Assis | SVP and GM, Life Sciences | 9,099 | 0.02% | Jul 29, 2026 |
| James P. Minicucci | SVP and GM, Personal Care | 8,567 | 0.02% | May 11, 2026 |
| William Whitaker | SVP, CFO & PFO | 2,082 | 0.00% | Nov 21, 2025 |
| Eileen Drury | SVP and Chief HRO | 7,601 | 0.02% | Nov 21, 2025 |
| Dago Caceres | SVP & GM, Specialty Additives | 746 | 0.00% | Nov 21, 2025 |
| Samuel Richardson | VP, Controller and PAO | 1,072 | 0.00% | Nov 21, 2025 |
| Eric N. Boni | VP, Finance & Prinpl Acctg Off | 22,770 | 0.05% | Dec 9, 2024 |
| J. Kevin Willis | SVP and CFO | 270,566 | 0.59% | Nov 20, 2024 |
| Karl R. Bostaph | Senior VP Operations | 7,165 | 0.02% | Nov 20, 2024 |
| Allen A. Spizzo | Director | – | – | Aug 5, 2026 |
| Peter T. Thomas | Director | 4,500 | 0.01% | Aug 5, 2026 |
| Steven D. Bishop | Director | – | – | Jul 1, 2026 |
| Sanat Chattopadhyay | Director | – | – | Jul 1, 2026 |
| Bertrand Loy | Director | – | – | May 18, 2026 |
| Ashish K. Kulkarni | Director | 2,113 | 0.00% | Jan 22, 2026 |
| Suzan F. Harrison | Director | 1,931 | 0.00% | Jan 22, 2026 |
| Sue Main | Director | 1,883 | 0.00% | Jan 21, 2026 |
| Jerome A. Peribere | Director | 1,883 | 0.00% | Jan 21, 2026 |
| Scott Tozier | Director | – | – | Jan 21, 2026 |
| Sergio Pedreiro | Director | – | – | Jan 23, 2025 |
| Janice Teal | Director | 1,883 | 0.00% | Jan 2, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Osama M. Musa SVP and CTO | Sep 21, 2026 | Tax withholding | −3,647 | $69.06 | $251.86K | 37,577 |
| Osama M. Musa SVP and CTO | Sep 21, 2026 | Option exercise | +10,418 | $69.06 | $719.47K | 41,224 |
| Robin E. Lampkin SVP, GC & Secretary | Aug 11, 2026 | Option exercise | +1,806 | $74.58 | $134.69K | 6,825 |
| Robin E. Lampkin SVP, GC & Secretary | Aug 11, 2026 | Tax withholding | −526 | $74.58 | $39.23K | 6,299 |
| Osama M. Musa SVP and CTO | Jul 29, 2026 | Option exercise | +1,267 | $57.96 | $73.44K | 30,806 |
| Alessandra Faccin Assis SVP and GM, Life Sciences | Jul 27, 2026 | Option exercise | +3,215 | $66.38 | $213.41K | 9,099 |
| Alessandra Faccin Assis SVP and GM, Life Sciences | Jul 27, 2026 | Tax withholding | −884 | $66.38 | $58.68K | 8,215 |
| James P. Minicucci SVP and GM, Personal Care | May 8, 2026 | Option exercise | +4,310 | $55.01 | $237.09K | 8,567 |
| James P. Minicucci SVP and GM, Personal Care | May 8, 2026 | Tax withholding | −1,346 | $55.01 | $74.04K | 7,221 |
| Ashish K. Kulkarni Director | Jan 21, 2026 | Option exercise | +2,113 | – | – | 2,113 |
| Samuel Richardson VP, Controller and PAO | Nov 17, 2025 | Tax withholding | −32 | $49.60 | $1.59K | 1,072 |
| Samuel Richardson VP, Controller and PAO | Nov 17, 2025 | Option exercise | +107 | $49.60 | $5.31K | 1,104 |
| Eileen Drury SVP and Chief HRO | Nov 17, 2025 | Tax withholding | −280 | $49.60 | $13.89K | 7,601 |
| Eileen Drury SVP and Chief HRO | Nov 17, 2025 | Option exercise | +567 | $49.60 | $28.12K | 7,881 |
| Osama M. Musa SVP and CTO | Nov 17, 2025 | Option exercise | +976 | $49.60 | $48.41K | 29,875 |
| Osama M. Musa SVP and CTO | Nov 17, 2025 | Tax withholding | −335 | $49.60 | $16.62K | 29,540 |
| William Whitaker SVP, CFO & PFO | Nov 17, 2025 | Option exercise | +107 | $49.60 | $5.31K | 2,082 |
| William Whitaker SVP, CFO & PFO | Nov 17, 2025 | Tax withholding | −33 | $49.60 | $1.64K | 2,049 |
| Guillermo Novo Chair of the Board and CEO, Director | Nov 17, 2025 | Tax withholding | −2,563 | $49.60 | $127.12K | 140,849 |
| Guillermo Novo Chair of the Board and CEO, Director | Nov 17, 2025 | Option exercise | +6,122 | $49.60 | $303.65K | 143,412 |
| Robin E. Lampkin SVP, Gen Counsel and Secrty. | Nov 17, 2025 | Option exercise | +239 | $49.60 | $11.85K | 5,095 |
| Robin E. Lampkin SVP, Gen Counsel and Secrty. | Nov 17, 2025 | Tax withholding | −72 | $49.60 | $3.57K | 5,023 |
| Osama M. Musa SVP and CTO | Nov 14, 2025 | Tax withholding | −717 | $51.51 | $36.93K | 28,899 |
| Osama M. Musa SVP and CTO | Nov 14, 2025 | Option exercise | +2,091 | $51.51 | $107.71K | 29,616 |
| Samuel Richardson VP, Controller and PAO | Nov 14, 2025 | Option exercise | +228 | $51.51 | $11.74K | 1,066 |
| Samuel Richardson VP, Controller and PAO | Nov 14, 2025 | Tax withholding | −69 | $51.51 | $3.55K | 997 |
| James P. Minicucci SVP and GM, Personal Care | Nov 14, 2025 | Option exercise | +1,225 | $51.51 | $63.10K | 4,640 |
| James P. Minicucci SVP and GM, Personal Care | Nov 14, 2025 | Tax withholding | −383 | $51.51 | $19.73K | 4,257 |
| Robin E. Lampkin SVP, Gen Counsel and Secrty. | Nov 14, 2025 | Option exercise | +1,276 | $51.51 | $65.73K | 5,237 |
| Robin E. Lampkin SVP, Gen Counsel and Secrty. | Nov 14, 2025 | Tax withholding | −381 | $51.51 | $19.63K | 4,856 |
| Eileen Drury SVP and Chief HRO | Nov 14, 2025 | Option exercise | +1,297 | $51.51 | $66.81K | 7,917 |
| Eileen Drury SVP and Chief HRO | Nov 14, 2025 | Tax withholding | −603 | $51.51 | $31.06K | 7,314 |
| Guillermo Novo Chair of the Board and CEO, Director | Nov 14, 2025 | Tax withholding | −3,817 | $51.51 | $196.61K | 137,290 |
| Guillermo Novo Chair of the Board and CEO, Director | Nov 14, 2025 | Option exercise | +9,119 | $51.51 | $469.72K | 141,107 |
| William Whitaker SVP, CFO & PFO | Nov 14, 2025 | Tax withholding | −108 | $51.51 | $5.56K | 1,975 |
| William Whitaker SVP, CFO & PFO | Nov 14, 2025 | Option exercise | +356 | $51.51 | $18.34K | 2,083 |
| Osama M. Musa SVP and CTO | Nov 13, 2025 | Option exercise | +1,393 | $53.10 | $73.97K | 28,002 |
| Osama M. Musa SVP and CTO | Nov 13, 2025 | Tax withholding | −477 | $53.10 | $25.33K | 27,525 |
| Samuel Richardson VP, Controller and PAO | Nov 13, 2025 | Option exercise | +146 | $53.10 | $7.75K | 882 |
| Samuel Richardson VP, Controller and PAO | Nov 13, 2025 | Tax withholding | −44 | $53.10 | $2.34K | 838 |
| James P. Minicucci SVP and GM, Personal Care | Nov 13, 2025 | Tax withholding | −319 | $53.10 | $16.94K | 3,415 |
| James P. Minicucci SVP and GM, Personal Care | Nov 13, 2025 | Option exercise | +1,020 | $53.10 | $54.16K | 3,734 |
| Dago Caceres SVP & GM, Specialty Additives | Nov 13, 2025 | Option exercise | +746 | $53.10 | $39.61K | 746 |
| Dago Caceres SVP & GM, Specialty Additives | Nov 13, 2025 | Tax withholding | −215 | $53.10 | $11.42K | 531 |
| Robin E. Lampkin SVP, Gen Counsel and Secrty. | Nov 13, 2025 | Option exercise | +866 | $53.10 | $45.98K | 4,220 |
| Robin E. Lampkin SVP, Gen Counsel and Secrty. | Nov 13, 2025 | Tax withholding | −259 | $53.10 | $13.75K | 3,961 |
| Eileen Drury SVP and Chief HRO | Nov 13, 2025 | Option exercise | +863 | $53.10 | $45.83K | 7,020 |
| Eileen Drury SVP and Chief HRO | Nov 13, 2025 | Tax withholding | −400 | $53.10 | $21.24K | 6,620 |
| Alessandra Faccin Assis SVP and GM, Life Sciences | Nov 13, 2025 | Option exercise | +1,340 | $53.10 | $71.15K | 6,286 |
| Alessandra Faccin Assis SVP and GM, Life Sciences | Nov 13, 2025 | Tax withholding | −570 | $53.10 | $30.27K | 5,716 |
| Guillermo Novo Chair of the Board and CEO, Director | Nov 13, 2025 | Tax withholding | −3,779 | $53.10 | $200.66K | 131,988 |
| Guillermo Novo Chair of the Board and CEO, Director | Nov 13, 2025 | Option exercise | +9,029 | $53.10 | $479.44K | 135,767 |
| William Whitaker SVP, CFO & PFO | Nov 13, 2025 | Option exercise | +229 | $53.10 | $12.16K | 1,797 |
| William Whitaker SVP, CFO & PFO | Nov 13, 2025 | Tax withholding | −70 | $53.10 | $3.72K | 1,727 |
| Alessandra Faccin Assis SVP and GM, Life Sciences | Jul 25, 2025 | Tax withholding | −1,327 | $51.26 | $68.02K | 4,946 |
| Alessandra Faccin Assis SVP and GM, Life Sciences | Jul 25, 2025 | Option exercise | +3,123 | $51.26 | $160.08K | 6,273 |
| James P. Minicucci SVP and GM, Personal Care | May 8, 2025 | Option exercise | +1,395 | $49.99 | $69.74K | 3,149 |
| James P. Minicucci SVP and GM, Personal Care | May 8, 2025 | Tax withholding | −435 | $49.99 | $21.75K | 2,714 |
| Ashish K. Kulkarni Director | May 6, 2025 | Option exercise | +1,032 | – | – | 1,032 |
| Guillermo Novo Chair of the Board and CEO, Director | Jan 31, 2025 | Buy | +31,294 | $64.24 | $2.01M | 31,294 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Eric N. Boni Officer | Dec 5, 2024 | 451 | $35.21K | Dec 5, 2024 | Stock Appreciation Rights |
| Robin E. Lampkin Officer | Nov 19, 2024 | 162 | $12.24K | Nov 19, 2024 | Restricted Stock Vesting |
| Robin E. Lampkin Officer | Nov 15, 2024 | 868 | $67.62K | Nov 15, 2024 | Restricted Stock Vesting |
| J. Kevin Willis Officer | Sep 4, 2024 | 5,487 | $482.20K | Sep 4, 2024 | SAR |
| Swaminathan Ashok Kalyana Former Officer | Jun 3, 2024 | 6,829 | $677.11K | Jun 3, 2024 | Open Market Purchase |
| Min Chong Former Officer | May 7, 2024 | 758 | $74.74K | May 7, 2024 | Stock Appreciation Rights |
| Robin E. Lampkin Officer | Feb 16, 2024 | 844 | $78.10K | Feb 16, 2024 | Restricted Stock Vesting |
| Eric N. Boni Officer | Dec 7, 2023 | 843 | $69.45K | Dec 7, 2023 | Stock Appreciation Rights |
| J. Kevin Willis Officer | Sep 5, 2023 | 7,866 | $680.72K | Sep 5, 2023 | SAR |